- Filed
- Nov 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Oct 21, 2024 | 181.02M sh |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $3.83B |
| Long Term Debt | Q2 2025 · Mar 31, 2024 | $3.82B |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $1.25B |
| Cash And Equivalents | Q2 2025 · Mar 31, 2024 | $1.22B |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $2.98B |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $2.81B |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $4B |
| Current Liabilities | Q2 2025 · Mar 31, 2024 | $4.39B |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $10.27B |
| Total Liabilities | Q2 2025 · Mar 31, 2024 | $10.81B |
| Current Assets | Q2 2025 · Sep 30, 2024 | $5.01B |
| Current Assets | Q2 2025 · Mar 31, 2024 | $5.14B |
| Total Assets | Q2 2025 · Sep 30, 2024 | $13.5B |
| Total Assets | Q2 2025 · Mar 31, 2024 | $13.87B |
| Shares Diluted | Q2 2025 · Sep 30, 2023 | 203.06M sh |
| Shares Diluted | Q2 2025 · Sep 30, 2023 | 208.9M sh |
| Stock Repurchased | Q2 2025 · Sep 30, 2023 | $505M |
| Capex | Q2 2025 · Sep 30, 2023 | $108M |
| Operating Cash Flow | Q2 2025 · Sep 30, 2023 | $375M |
| Eps Diluted | Q2 2025 · Sep 30, 2023 | $0.49 |
| Eps Diluted | Q2 2025 · Sep 30, 2023 | $0.65 |
| Eps Basic | Q2 2025 · Sep 30, 2023 | $0.49 |
| Eps Basic | Q2 2025 · Sep 30, 2023 | $0.66 |
| Sga Expense | Q2 2025 · Sep 30, 2023 | $328M |
| Sga Expense | Q2 2025 · Sep 30, 2023 | $655M |
| Net Income | Q2 2025 · Sep 30, 2023 | $99M |
| Net Income | Q2 2025 · Sep 30, 2023 | $135M |
| Operating Income | Q2 2025 · Sep 30, 2023 | $251M |
| Operating Income restated | Q2 2025 · Sep 30, 2023 | $469M |
| Revenue | Q2 2025 · Sep 30, 2023 | $3.44B |
| Revenue | Q2 2025 · Sep 30, 2023 | $6.88B |